Empagliflozin STELLA 25 mg

Rx

Indications

• Blood glucose control: Used in conjunction with diet and exercise to lower blood glucose in adult and pediatric patients 10 years of age and older with type 2 diabetes.
• Cardiovascular protection: Reduces the risk of hospitalization for heart failure and death from cardiovascular disease in adults with type 2 diabetes.
• Renal protection: Reduces the risk of progression of chronic kidney disease in adults.

Dosage

• Starting dose: Usually 10 mg once daily.
• Maximum dose: May be increased to 25 mg once daily if necessary and well tolerated.
• No dose adjustment is needed in patients with hepatic impairment or the elderly.

Usage

• Swallow the tablet whole with water, once in the morning, with or without food.

• Hypersensitivity to empagliflozin or to any of the excipients of the drug.

• Urinary tract infection, vaginal yeast infection, balanitis.
• Dehydration, dizziness, dry mouth, hypoglycemia.
• Rare: Diabetic ketoacidosis.

• Empagliflozin should not be used in patients with type 1 diabetes mellitus and ketoacidosis, patients with end-stage renal disease or undergoing dialysis.
• This medication should not be used in patients with rare hereditary problems of galactose intolerance, total lactase deficiency, or glucose-galactose malabsorption.
• This medication contains less than 1 mmol (23 mg) of sodium per tablet, and is essentially considered “sodium-free”.
• Avoid the use of empagliflozin during pregnancy and lactation.
• Empagliflozin has minor influence on the ability to drive and use machines. Patients should be aware of how they react to drug before driving or operating machinery.